美国临床药师职业发展方向(PDF)

Desired Professional Development Pathways for Clinical Pharmacists

The 2012 American College of Clinical Pharmacy (ACCP) Certification Affairs Committee was charged with developing guidelines for the desired professional development pathways for clinical pharmacists. This document summarizes recommendations for postgraduate education and training for graduates of U.S. schools and colleges of pharmacy and describes the preferred pathways for achieving, demonstrating, and maintaining competence as clinical pharmacists. After initial licensure within the state or jurisdiction in which the pharmacist intends to practice, completion of an accredited PGY1 pharmacy residency is recommended to further develop the knowledge and skills needed to optimize medication therapy outcomes.

An accredited PGY2 pharmacy residency should be completed if a pharmacist wishes to seek employment in a specific therapeutic area or practice setting, if such a residency exists. Clinical pharmacists intending to conduct advanced research that is competitive for federal funding are encouraged to complete a fellowship or graduate education. Initial certification by the Board of Pharmacy Specialties (BPS) or other appropriate sponsoring organizations should be completed in the desired primary therapeutic area or practice setting within 2 years after accepting a position within the desired specific therapeutic area or practice setting. Clinical pharmacists subsequently will need to meet the requirements to maintain pharmacist licensure and board certification.

Traineeships, practice-based activities, and certificate programs can be used to obtain additional knowledge and skills that support professional growth. Pharmacists are strongly encouraged to adopt a lifelong, systematic process for professional development and work with ACCP and other professional organizations to facilitate the development and implementation of innovative strategies to assess core practice competencies.

Key Words: clinical pharmacist, professional development, pharmacy residency, board certification, pharmacy fellowship, continuing pharmacy education.

(Pharmacotherapy 2013;33(4):e34–e42)

For more information and the full PDF file please visit Pharmacy Profession Forum at http://forum.tomhsiung.com/pharm ... acists.html#post219

翻译一下下，造福中国人。

临床药师所需的专业发展之路

2012年美国大学临床药学（ACCP）认证委员会负责制定指导方针所需的专业临床药师的发展途径。本文件总结了研究生教育和培训的建议，并介绍了美国学校和学院药学毕业生的首选途径实现，示范，临床药师和维护能力。州内或管辖区的药剂师打算实践的初始执照后，完成认可的一般医学药房居住的建议，以进一步发展所需要的知识和技能，以优化药物治疗的结果。

应完成认可的PGY2药房居住，如果药剂师希望寻求就业在一个特定的治疗领域或惯例设定，如果存在这种居留。鼓励临床药师有意进行先进的研究是有竞争力的联邦资助，以完成一项奖学金或研究生教育。药学专业（BPS）或其他适当的发起组织委员会的初步认证所需的主要治疗领域或实践设置应完成后两年内接受所需的特定治疗领域或实践设置内的位置。临床药师随后将需要满足的要求，以保持药剂师执照和电路板认证。

公司培训，以实践为基础的活动，和证书课程可以用来获得更多的知识和技能，支持专业成长。药剂师强烈鼓励采取终身的，专业发展和系统化的过程，ACCP等专业机构合作，促进发展和实施创新战略，以评估核心业务竞争力。

关键词：临床药师，专业发展，药店居留，董事会认证，药店奖学金，继续教育药店。